Lifetech Approved to Obtain Two Key National R&D Program Projects

In 2018, Lifetech was approved to obtain two key national R&D program projects, namely "bio-functionalized new medical metal materials and industrialization" project initiated by Lifetech, which is supported by the national key R&D program "Biomedical Material Research and Development and Tissue & Organ Repair Alternative Special Project"; and "Application Demonstration and Evaluation Research on Congenital Heart Disease and Cleft Lip and Palate Three-Level Comprehensive Prevention and Control Technology" initiated by Guangdong Cardiovascular Institute and jointly applied by Lifetech, which is supported by the national key R&D program "Reproductive Health and Major Birth Defect Prevention and Control Research Project".


This project is the national key R&D program project approved to Lifetech the third time. Before then, Lifetech has obtained 1 project of National "973" Program, 2 projects of National "863" Program, and 2 national key R&D projects. Through these projects obtained, its powerful independent innovation and scientific research strength is demonstrated, and its technological innovation strength is highly recognized by the government.

 

The national key R&D program is a combination of the original National "973" Program, National "863" Program, national science and technology support program, international science and technology cooperation and exchange special projects. It aims at major social welfare research concerning the national economy and people's livelihood, as well as the major scientific and technological issues concerning industrial core competitiveness, overall independent innovation capability and national security, with a view to breaking the technical bottlenecks in the main areas of national economic and social development.

 

The "Biomedical Material Research and Development and Tissue & Organ Repair Alternative Special Project" initiated and applied by Lifetech aims to reveal the biological functionalization mechanism of new medical metals, and break through key preparation techniques such as material purification, homogenization and micro-nanometer, so as to build volume production and stable quality full-process industrialized production lines for bio-functionalized new medical metals. Thus, in the fields of orthopedics, dentistry, vascular stents, etc., anti-infective, osteogenic, low elastic modulus, shape memory and degradable medical metals and medical devices will be developed to lay the foundation for material industrialization in a wide range of clinical applications in the fields of orthopedics, dentistry and vascular stents.